About China Resources Double-Crane Pharmaceutical Company

The company has a glorious history of 84 years. It was founded in 1939. It was originally a military pharmaceutical factory at the Taihang Mountain Revolutionary Base, known externally as Lihua Pharmaceutical Factory; moved to Beijing with the army in 1949, then changed its name to Beijing Pharmaceutical Factory, and developed into a large-scale state-owned comprehensive chemical pharmaceutical enterprise, laying the foundation for the modern chemical pharmaceutical industry in Beijing; in 1997, it integrated high-quality assets to establish Shuanghe Pharmaceutical, listed on the Shanghai Stock Exchange, and became a cross-regional group based in Beijing and the country through expansion; it entered China Resources Group, one of the world's top 500 enterprises in 2010, and is now renamed Huarun Shuanghe. China Resources Group University One of the business units in the health sector. The company is mainly engaged in drug development, manufacturing and sales. The company's main products include compounded reserxepine tablets (no. 0), amlodipine benzenesulfonate tablets (pressure), gliquanone tablets (sugar level), citicoline sodium tablets (norbeil), magnesium valproate sustained-release tablets (Shentai), pentazocin, lidocaine, parecoxib sodium, encapsulated polypropylene infusion (BFS), etc. Corporate honors: “Beijing Municipal People's Government Quality Management Award”, “High-tech Enterprise”, “Top 100 Comprehensive Industrial Enterprises in China's Chemical and Pharmaceutical Industry”, and “Top 100 Chinese Chemical Pharmaceutical Enterprises”.